# Xiaohui Xie

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaohui-xie/

## Facts

| Field | Value |
| --- | --- |
| Citations | 407 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 10 |
| i10-index | 12 |
| Last Known Institution | Neijiang Normal University |
| OpenAlex ID | https://openalex.org/A5056607681 |
| ORCID iD | 0000-0002-2852-4493 |
| Works | 36 |

## Researcher papers

- [Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data](https://scholariq.org/papers/prediction-of-overall-survival-for-patients-with-metastatic-castration-resistant/)
- [Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis](https://scholariq.org/papers/clinical-value-of-different-anti-d-immunoglobulin-strategies-for-preventing-rh/)
- [The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis](https://scholariq.org/papers/the-impact-of-smoking-status-on-the-progression-free-survival-of-non-small-cell/)
- [Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study](https://scholariq.org/papers/lenvatinib-plus-sintilimab-versus-lenvatinib-monotherapy-as-first-line-treatment/)
- [Continuous Versus Intermittent use of Furosemide in Patients with Heart Failure and Moderate Chronic Renal Dysfunction](https://scholariq.org/papers/continuous-versus-intermittent-use-of-furosemide-in-patients-with-heart-failure/)
- [A narrative review: depth of response as a predictor of the long-term outcomes for solid tumors](https://scholariq.org/papers/a-narrative-review-depth-of-response-as-a-predictor-of-the-long-term-outcomes/)
- [Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/risk-of-urinary-tract-infection-in-patients-with-type-2-diabetes-mellitus/)
- [Low serum vitamin D concentration is correlated with anemia, microinflammation, and oxidative stress in patients with peritoneal dialysis](https://scholariq.org/papers/low-serum-vitamin-d-concentration-is-correlated-with-anemia-microinflammation/)
- [Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights](https://scholariq.org/papers/dose-escalation-studies-of-mesenchymal-stromal-cell-therapy-for-decompensated/)
- [Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non–small‐cell lung cancer patients: A network meta‐analysis](https://scholariq.org/papers/hepatotoxicity-with-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)

## Researcher university

- [Neijiang Normal University](https://scholariq.org/institutions/neijiang-normal-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.